Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 25 tags : Europe save search
Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO®, SYMKEVI® and Additional Indications of ORKAMBI® and KALYDECO® for Eligible Patients With Cystic Fibrosis
Published: 2021-06-25 (Crawled : 21:00) - biospace.com/
VRTX | $404.015 1.02% 120K
|
Health Technology
|
| O: 0.03%
H: 1.45%
C: 1.22%
fibrosis cystic fibrosis
Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-06-25 (Crawled : 12:15) - biospace.com/
XNCR | $18.72 2.8% 34K
|
Health Technology
|
| O: 0.06%
H: 2.35%
C: 0.75%
MOR | News | $18.06 0.56% 35K
|
Health Technology
|
| O: 2.89%
H: 0.23%
C: -0.55%
INCY | $51.475 -0.86% 230K
|
Health Technology
|
| O: -0.71%
H: 1.74%
C: 1.53%
treatment positive chmp t-cell
BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Published: 2021-06-25 (Crawled : 12:00) - investors.biomarin.com
BMRN | $91.615 2.38% 340K
|
Health Technology
|
| O: 0.66%
H: 1.39%
C: 0.55%
treatment europe drop positive children growth chmp achondroplasia
Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA)
Published: 2021-06-25 (Crawled : 10:00) - biospace.com/
AUPH | $5.085 0.69% 220K
|
Health Technology
|
| O: 0.0%
H: 2.77%
C: -0.97%
europe license authorized ema application
Libtayo® (cemiplimab) Approved by the European Commission for First-Line Treatment of Patients with Advanced Non-small Cell Lung Cancer with ≥50% PD-L1 Expression
Published: 2021-06-25 (Crawled : 06:00) - prnewswire.com
SNY | News | $47.375 0.48% 300K
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
REGN | News | $908.53 0.93% 40K
|
Health Technology
|
| O: -0.16%
H: 1.64%
C: 1.28%
treatment lung cancer europe cancer
Libtayo® (cemiplimab) Approved by the European Commission as the First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
Published: 2021-06-25 (Crawled : 06:00) - prnewswire.com
SNY | News | $47.375 0.48% 300K
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
REGN | News | $908.53 0.93% 40K
|
Health Technology
|
| O: -0.16%
H: 1.64%
C: 1.28%
immunotherapy europe therapy cell carcinoma
Industrial Robotics Market in Europe in Industrial Machinery Sector: Incremental Growth is Expected to be Worth $ 2.51 Billion by 2025
Published: 2021-06-25 (Crawled : 06:00) - prnewswire.com
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: 0.87%
H: 0.12%
C: -0.32%
europe growth trial
Sanofi: Libtayo® (cemiplimab) approved by the European Commission for first-line treatment of patients with advanced non-small cell lung cancer with ≥50% PD-L1 expression
Published: 2021-06-25 (Crawled : 06:00) - globenewswire.com
SNY | News | $47.375 0.48% 300K
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
REGN | News | $908.53 0.93% 40K
|
Health Technology
|
| O: -0.16%
H: 1.64%
C: 1.28%
treatment lung cancer europe cancer
Sanofi: Libtayo® (cemiplimab) approved by the European Commission as the first immunotherapy indicated for patients with advanced basal cell carcinoma
Published: 2021-06-25 (Crawled : 06:00) - globenewswire.com
SNY | News | $47.375 0.48% 300K
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
REGN | News | $908.53 0.93% 40K
|
Health Technology
|
| O: -0.16%
H: 1.64%
C: 1.28%
immunotherapy europe therapy cell carcinoma
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.46 96.8% 28M
|
Finance
EDBL | News | $6.94 84.57% 1.4M
|
CZOO | $7.74 55.11% 2.7M
|
ZAPP | $6.02 35.59% 95K
|
n/a
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
VNRX | $0.759 26.5% 390K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.